The phase III SOLO-1 trial demonstrated a long-term progression-free survival benefit of Lynparza versus placebo as a first-line maintenance treatment in patients with newly diagnosed, advanced BRCA-mutated ovarian cancer who were in complete or partial response to platinum-based chemotherapy.
Verzenio significantly reduces risk of cancer recurrence in HR+, HER2- high risk early breast cancer
Verzenio (abemaciclib) in combination with standard adjuvant endocrine therapy significantly decreased the risk of breast cancer recurrence by 25% compared to standard adjuvant ET alone for people with hormone receptor-positive, human epidermal growth factor receptor 2-negative high risk early breast cancer (HR: 0.747; 95% CI: 0.598, 0.932; p = 0.0096).
The phase III trial of Padcev (enfortumab vedotin-ejfv) met its primary endpoint of overall survival compared to chemotherapy.
The DKMS Stiftung Leben Spenden (Foundation for Giving Life) plans to support up to four international young scientists each year who want to advance the fight against blood cancer with their research projects, especially in the field of blood stem cell transplantation and cell therapy.
Thermo Fisher Scientific has introduced the Oncomine Clinical Research Grant Program to support clinical research projects in oncology and reproductive health.
The Montefiore Health System and Albert Einstein College of Medicine have received a five-year, $111 million grant from NCI to lead the AIDS Malignancy Consortium.
Hospital executive James (Jamie) Bachman was named chief administrative officer for the Sidney Kimmel Comprehensive Cancer Center,.
Mark Hurwitz was named to the new position of SKCC enterprise cancer quality and safety officer, and Valerie Csik was named director of cancer quality and care transformation at the Sidney Kimmel Cancer Center–Jefferson Health.
Theresa (Tess) Cummings, was named director of UNC Lineberger's Clinical Protocol Office.
The Tisch Cancer Institute at Mount Sinai has received $13 million as part of the renewal of its NCI Cancer Center Designation.
